TickerFactsScreenerDevelopers

Verrica Pharmaceuticals Inc. (VRCA) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2016: $527.0K2017: $8.66M2018: $10.27M2019: $9.24M2020: $10.69M2021: $15.75M2022: $34.27M2023: $69.55M2024: $46.33M2025: $30.15M$30.15M
2016Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$30.15M-34.9%
2024$46.33M-33.4%
2023$69.55M+102.9%
2022$34.27M+117.6%
2021$15.75M+47.4%
2020$10.69M+15.6%
2019$9.24M-10.0%
2018$10.27M+18.6%
2017$8.66M+1543.8%
2016$527.0K—